Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells-Reference-Cited by-同舟云学术

Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells

Published:2017-03-17 Issue:18 Volume:8 Page:30276-30287
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liao Yunfei¹²,Chen Lulu¹,Feng Yong²³,Shen Jacson²,Gao Yan²,Cote Gregory⁴,Choy Edwin⁴,Harmon David⁴,Mankin Henry²,Hornicek Francis²,Duan Zhenfeng²

Affiliation:

1. Department of Endocrinology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

2. Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston 02114, Massachusetts, USA

3. Department of Orthopaedic Surgery, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

4. Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, Massachusetts, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas-Mediated Knockdown of PD-L1 and KRAS in Lung Cancer Cells;International Journal of Molecular Sciences;2024-08-22

2. Engineering CRISPR/Cas9 therapeutics for cancer precision medicine;Frontiers in Genetics;2024-04-25

3. CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy;Pharmaceutics;2024-03-01

4. CRISPR-Cas9: A Potent Gene-editing Tool for the Treatment of Cancer;Current Molecular Medicine;2024-02

5. CRISPR-Cas9 Unleashed: Gene-Slicing Adventures in the Cancer Battlefield;Cancer Insight;2024-01-02